Acorda Therapeutics, Inc. - Company Profile and SWOT Analysis
SummaryAcorda Therapeutics, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Acorda Therapeutics, Inc. (Acorda or 'the company') is involved in the identification, development and commercialization of novel therapies to treat neurological disorders. It is also engaged in the development and marketing of therapies to assist restore function in individuals with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company also offers various pipeline products to neurological therapies including heart failure, migraine, Primary Sclerosing Cholangitis, MS, spinal cord injury and various other disorders. Acorda markets products under Zanaflex, Ampyra or Fampyra (dalfampridine); Inbrija, BTT1023 and GGF2 brands. It develops additional inhaled medicines for both systemic and pulmonary conditions. Acorda primarily operates in the US. The company is headquartered in Ardsley, New York, the US.
Scope
- Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments
- Intelligence on Acorda Therapeutics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Acorda Therapeutics, Inc.'s business structure, strategy and prospects.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.